204 related articles for article (PubMed ID: 1495505)
1. Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies.
Yuki N; Yoshino H; Sato S; Shinozawa K; Miyatake T
Muscle Nerve; 1992 Aug; 15(8):899-903. PubMed ID: 1495505
[TBL] [Abstract][Full Text] [Related]
2. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
[TBL] [Abstract][Full Text] [Related]
3. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome.
Yuki N; Yamada M; Sato S; Ohama E; Kawase Y; Ikuta F; Miyatake T
Muscle Nerve; 1993 Jun; 16(6):642-7. PubMed ID: 8502262
[TBL] [Abstract][Full Text] [Related]
4. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
5. [Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni enteritis].
Tsuda N; Negoro K; Morimatsu M; Saito K; Yuki N
Rinsho Shinkeigaku; 1995 Feb; 35(2):208-10. PubMed ID: 7781242
[TBL] [Abstract][Full Text] [Related]
6. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
[TBL] [Abstract][Full Text] [Related]
7. [An acute axonal form of Guillain-Barré syndrome with antibodies against gangliosides GM1 and GD1b--a case report].
Yuki N; Yoshino H; Sato S; Ohno T; Miyatake T
Rinsho Shinkeigaku; 1990 Sep; 30(9):989-93. PubMed ID: 2265511
[TBL] [Abstract][Full Text] [Related]
8. [Axonal Guillain-Barré syndrome associated with antibodies to Ga1NAc-GD1a and unidentified acidic glycolipids].
Ono M; Sakai T; Ohnishi A; Hashimoto T; Yuki N
Rinsho Shinkeigaku; 1997 Feb; 37(2):119-22. PubMed ID: 9164143
[TBL] [Abstract][Full Text] [Related]
9. N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome.
Kusunoki S; Chiba A; Kon K; Ando S; Arisawa K; Tate A; Kanazawa I
Ann Neurol; 1994 May; 35(5):570-6. PubMed ID: 8179303
[TBL] [Abstract][Full Text] [Related]
10. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
[TBL] [Abstract][Full Text] [Related]
11. Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides.
Illa I; Ortiz N; Gallard E; Juarez C; Grau JM; Dalakas MC
Ann Neurol; 1995 Aug; 38(2):218-24. PubMed ID: 7654069
[TBL] [Abstract][Full Text] [Related]
12. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
Shimoya K; Ohnishi A; Hashimoto T; Yuki N
Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
[TBL] [Abstract][Full Text] [Related]
13. Anti-GD1a ganglioside antibodies in peripheral motor syndromes.
Carpo M; Nobile-Orazio E; Meucci N; Gamba M; Barbieri S; Allaria S; Scarlato G
Ann Neurol; 1996 Apr; 39(4):539-43. PubMed ID: 8619533
[TBL] [Abstract][Full Text] [Related]
14. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
15. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
Ogawa G; Kaida K; Kuwahara M; Kimura F; Kamakura K; Kusunoki S
J Neuroimmunol; 2013 Jan; 254(1-2):141-5. PubMed ID: 23000056
[TBL] [Abstract][Full Text] [Related]
16. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL
Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
[TBL] [Abstract][Full Text] [Related]
17. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
18. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection.
Rees JH; Gregson NA; Hughes RA
Ann Neurol; 1995 Nov; 38(5):809-16. PubMed ID: 7486873
[TBL] [Abstract][Full Text] [Related]
19. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG
Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
[TBL] [Abstract][Full Text] [Related]
20. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
